WAL0921 for Healthy Subjects
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new drug called WAL0921 in healthy people to see if it is safe and understand how it moves through and affects the body.
Will I have to stop taking my current medications?
The trial is for healthy individuals without current medical conditions, so participants likely should not be on any medications. The protocol does not specify, but it seems participants should not be taking regular medications.
What safety data exists for WAL0921 in healthy subjects?
There is general safety data from phase I studies involving healthy volunteers, which show that adverse events (unwanted effects from the treatment) can occur, but the frequency and seriousness vary. These studies help understand the safety of treatments like WAL0921, even if they were tested under different names or for other conditions.12345
Who Is on the Research Team?
Andrew Blair, MD
Principal Investigator
Walden Biosciences, Inc.
Are You a Good Fit for This Trial?
This trial is for healthy adults between the ages of 18 and 65 with a BMI between 18 and 32 kg/m2. Participants should not have any known current or chronic medical conditions.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a single intravenous infusion of WAL0921 or placebo
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Placebo
- WAL0921
Find a Clinic Near You
Who Is Running the Clinical Trial?
Walden Biosciences
Lead Sponsor